Direct and indirect suppression of interleukin-6 gene expression in murine macrophages by nuclear orphan receptor

Shogo Sato1, Takuya Sakurai1, Junetsu Ogasawara1

  • 1Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.

Thescientificworldjournal
|November 18, 2014
PubMed

Insights

REV-ERBα, a nuclear receptor, suppresses interleukin-6 (IL-6) gene expression in macrophages, acting as a key regulator of the inflammatory response and a potential therapeutic target for inflammatory diseases.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Immunology

Background:

  • Nuclear hormone receptors modulate gene expression.
  • REV-ERBα influences lipid metabolism, adipogenesis, and inflammation.
  • REV-ERBα links circadian clock function with inflammatory pathways.

Purpose of the Study:

  • To investigate REV-ERBα's role in regulating interleukin-6 (IL-6) gene expression in murine macrophages.
  • To elucidate the mechanisms by which REV-ERBα affects IL-6 expression.

Main Methods:

  • Utilized REV-ERBα agonists and overexpression in RAW264 macrophage cell line.
  • Administered lipopolysaccharide (LPS) to stimulate IL-6 induction.
  • Assessed nuclear factor κB (NFκB) activation.
  • Analyzed IL-6 promoter regions for REV-ERBα and NFκB binding sites.
  • Examined peritoneal macrophages from REV-ERBα knockout mice.

Main Results:

  • REV-ERBα agonists and overexpression suppressed LPS-induced IL-6 mRNA.
  • REV-ERBα overexpression reduced LPS-stimulated NFκB activation.
  • REV-ERBα directly represses IL-6 via its promoter binding motif and indirectly via NFκB.
  • Macrophages lacking REV-ERBα exhibited increased IL-6 mRNA expression.

Conclusions:

  • REV-ERBα acts as a negative regulator of IL-6 expression in macrophages.
  • REV-ERBα suppresses the inflammatory response by controlling IL-6.
  • REV-ERBα is a potential anti-inflammatory target for treating inflammatory diseases.